Prof. Dr. Emre Merdan Fayda
Prof. Dr. Emre Merdan Fayda
Education and Specialization
Istanbul University Istanbul Faculty of Medicine — Medical education, 1993–1999
Istanbul University Istanbul Faculty of Medicine — Specialization in Radiation Oncology, 1999–2004
University of North Carolina, Thoracic Oncology and Stereotactic Radiotherapy — Academic work, 2010–2011
Istanbul University Oncology Institute — Associate professorship, 2012–2015
Istinye University Faculty of Medicine — Professorship, 2017–
2016–2017: Associate professor, İstinye University Faculty of Medicine.
Areas of Expertise
Breast cancer
Gynecologic cancers
Urologic tumors
Gastrointestinal tumors
Central nervous system tumors
Skin cancers
Soft tissue tumors
Stereotactic radiotherapy
VMAT and intensity-modulated radiotherapy
Three-dimensional brachytherapy
MR-Linac
Head and neck cancers
Lung cancer
Central nervous system metastases
Professional Experience
2004–2005: Radiation oncology specialist and reserve officer, GATA.
Kocaeli University Department of Radiation Oncology — Academic work, 2006–2009
Liv Hospital Radiation Oncology — Clinical practice, 2015–
Liv Hospital Radiation Medicine Center, Tbilisi — Clinical practice, 2016–2019
Scientific and Professional Activities
National and international scientific publications and professional activities
Professional Memberships
Turkish Society for Radiation Oncology (TROD)
American Society for Radiation Oncology (ASTRO)
European Society for Radiotherapy and Oncology (ESTRO)
Scientific Publications
Articles
Fayda M. Having ypN0 may not be enough to abandon the Postmastectomy Radiotherapy (PMRT) in Her-2 positive patients. Radiother Oncol. 2023 Aug;185:109722. doi: 10.1016/j.radonc.2023.109722. Epub 2023 May 25. PMID: 37244359.
Turkkan G, Bilici N, Sertel H, Keskus Y, Alkaya S, Tavli B, Ozkirim M, Fayda M. Clinical utility of a 1.5 T magnetic resonance imaging-guided linear accelerator during conventionally fractionated and hypofractionated prostate cancer radiotherapy. Front Oncol. 2022 Aug 16;12:909402. doi: 10.3389/fonc.2022.909402. eCollection 2022. PMID: 36052268.
Karanlik H, Ozgur I, Sahin D, Fayda M, Onder S, Yavuz E. Intraoperative ultrasound reduces the need for re-excision in breast-conserving surgery. World J Surg Oncol. 2015 Nov 24;13:321. doi: 10.1186/s12957-015-0731-2. PMID: 26596699.
Yirmibesoglu E, Higginson DS, Fayda M, Rivera MP, Halle J, Rosenman J, Xie L, Marks LB. Challenges scoring radiation pneumonitis in patients irradiated for lung cancer. Lung Cancer. 2012 Jun;76(3):350-3. doi: 10.1016/j.lungcan.2011.11.025. Epub 2012 Jan 9. PMID: 22230037.
Ulutin C, Cetinayak O, Aksu G, Fayda M, Ataergin S, Beyzadeoğlu M. Malignant peripheral primitive neuroectodermal (pPNET) of tongue. Auris Nasus Larynx. 2007 Mar;34(1):115-8. doi: 10.1016/j.anl.2006.11.001. Epub 2007 Jan 19. PMID: 17240098.
Uygun K, Aksu G, Cicin I, Karagol H, Kocak Z, Fayda M, Binici A, Uzunoglu F. The efficiency of single agent docetaxel in patients with platinum-refractory non-small cell lung carcinoma. Med Oncol. 2008;25(4):408-14. doi: 10.1007/s12032-008-9055-1. Epub 2008 Mar 5. PMID: 18320363.
Aydiner A, Sen F, Tambas M, Ciftci R, Eralp Y, Saip P, Karanlik H, Fayda M, Kucucuk S, Onder S, Yavuz E, Muslumanoglu M, Igci A. Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment. Medicine (Baltimore). 2015 Dec;94(52):e2341. doi: 10.1097/MD.0000000000002341. PMID: 26717372.
Tambas M, Tavli B, Bilici N, Dizman A, Sertel H, Fayda M. Computed Tomography-Guided Optimization of Needle Insertion for Combined Intracavitary/Interstitial Brachytherapy With Utrecht Applicator in Locally Advanced Cervical Cancer. Pract Radiat Oncol. 2021 Jul-Aug;11(4):272-281. doi: 10.1016/j.prro.2021.01.008. Epub 2021 Feb 5. PMID: 33556579.
Ulutin C, Fayda M, Aksu G, Cetinayak O, Kuzhan O, Ors F, Beyzadeoglu M. Primary glioblastoma multiforme in younger patients: a single-institution experience. Tumori. 2006 Sep-Oct;92(5):407-11. doi: 10.1177/030089160609200507. PMID: 17168433.
Fayda M, Kebudi R, Dizdar Y, Gorgun O, Gun F, Aksu G, Ayan I. Spontaneous pneumothorax in children with osteosarcoma: report of three cases and review of the literature. Acta Chir Belg. 2012 Sep-Oct;112(5):378-81. doi: 10.1080/00015458.2012.11680856. PMID: 23175928.
Aksu G, Karadeniz A, Saynak M, Fayda M, Kadehci Z, Kocaelli H. Treatment results and prognostic factors in oral tongue cancer: analysis of 80 patients. Int J Oral Maxillofac Surg. 2006 Jun;35(6):506-13. doi: 10.1016/j.ijom.2006.01.006. Epub 2006 Feb 28. PMID: 16503396.
Aksu G, Kucucuk S, Fayda M, Saynak M, Baskaya S, Saip P, Ozturk N, Aslay I. The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease. Eur J Surg Oncol. 2007 Apr;33(3):285-93. doi: 10.1016/j.ejso.2006.10.037. Epub 2006 Dec 4. PMID: 17145158.
Uygun K, Bilici A, Karagol H, Caloglu M, Cicin I, Aksu G, Fayda M, Uzunoglu S. The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol. 2009 Aug;64(3):601-5. doi: 10.1007/s00280-008-0911-7. Epub 2009 Jan 3. PMID: 19123002.
Agaoglu FY, Fayda M, Dizdar Y, Basaran M, Yazar A, Darendeliler E. Primary uterine lymphoma: case report and literature review. Aust N Z J Obstet Gynaecol. 2005 Feb;45(1):88-9. doi: 10.1111/j.1479-828X.2005.00329.x. PMID: 15730377.
Saynak M, Aksu G, Fayda M, Kaytan E, Oral E, Gurocak S, Kizir A, Karadeniz A. The results of concomitant and sequential chemoradiotherapy with cisplatin and etoposide in patients with locally advanced non-small cell lung cancer. J BUON. 2005 Apr-Jun;10(2):213-8. PMID: 17343331.
Fayda M, Isin M, Tambas M, Guveli M, Meral R, Altun M, Sahin D, Ozkan G, Sanli Y, Isin H, Ozgur E, Gezer U. Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy? Tumour Biol. 2016 Mar;37(3):3969-78. doi: 10.1007/s13277-015-4189-1. Epub 2015 Oct 19. PMID: 26482616.
Yalug I, Corapcioglu F, Fayda M, Aksu G, Basar E, Yalug K, Aker T. Posttraumatic stress disorder and risk factors in parents of children with a cancer diagnosis. Pediatr Hematol Oncol. 2008 Jan-Feb;25(1):27-38. doi: 10.1080/08880010701704048. PMID: 18231952.
Ulutin HC, Aksu G, Fayda M, Kuzhan O, Tahmaz L, Beyzadeoglu M. The value of postoperative radiotherapy in renal cell carcinoma: a single-institution experience. Tumori. 2006 May-Jun;92(3):202-6. doi: 10.1177/030089160609200303. PMID: 16869236.
Duman E, Karahan S, Tavli B, Sertel H, Fayda M. Computed Tomography Guided Brachytherapy With Hybrid Applicators: An Effective Curative Treatment for Vaginal Cuff Recurrences. Pract Radiat Oncol. 2026 Jan-Feb;16(1):74-85. doi: 10.1016/j.prro.2025.06.004. Epub 2025 Jun 28. PMID: 40588213.
Bakkal BH, Kaya B, Berberoglu S, Aksu G, Sayin MY, Altundag MB, Fayda M. The efficiency of different chemoradiotherapy regimens in patients with paediatric nasopharynx cancer: review of 46 cases. Int J Clin Pract. 2007 Jan;61(1):52-61. doi: 10.1111/j.1742-1241.2006.00872.x. Epub 2006 Jun 19. PMID: 16787436.
Arslan M, Karadeniz AN, Aksu G, Güveli M, Fayda M, Doğan AK, Akyüz F. Postoperative hypofractionated radiotherapy in glioblastoma multiforme. J BUON. 2006 Jan-Mar;11(1):39-42. PMID: 17318950.
Inan N, Fayda M, Aksu G, Akansel G, Muezzinoglu B, Arslan A. Leiomyoma of the seminal vesicle mimicking tumoral extension of prostatic carcinoma. Acta Chir Belg. 2009 Nov-Dec;109(6):811-4. doi: 10.1080/00015458.2009.11680546. PMID: 20184078.
Onder S, Fayda M, Karanlık H, Bayram A, Şen F, Cabioglu N, Tuzlalı S, İlhan R, Yavuz E. Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis. Breast J. 2017 Nov;23(6):638-646. doi: 10.1111/tbj.12823. Epub 2017 May 23. PMID: 28543794.
Gurdal N, Fayda M, Alishev N, Bakir B, Tastekin D, Aykan F, Gezer U, Balik E, Saglam EK, Oral EN, Gulluoglu M, Kizir A. Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers. Tumori. 2018 Aug;104(4):266-272. doi: 10.5301/tj.5000702. Epub 2018 May 8. PMID: 29218690.
Fayda M, Tambaş M, Karanlık H. Is sentinel lymph node biopsy enough for axillary macrometastasis? Ulus Cerrahi Derg. 2015 Dec 1;31(4):253-5. doi: 10.5152/UCD.2015.3076. eCollection 2015. PMID: 26668538.
Karadeniz A, Saynak M, Kadehci Z, Fayda M, Aksu G, Kocaelli H, Hafiz G. [The results of combined treatment (surgery and postoperative radiotherapy) for tongue cancer and prognostic factors]. Kulak Burun Bogaz Ihtis Derg. 2007;17(1):1-6. PMID: 17483603.
Aksu G, Fayda M, Sakar B, Kapran Y. Colon cancer with isolated metastasis to the kidney at the time of initial diagnosis. Int J Gastrointest Cancer. 2003;34(2-3):73-7. doi: 10.1385/IJGC:34:2-3:073. PMID: 15361638.
Aksu G, Fayda M, Saynak M, Tore G, Alatli C. Is early postradiation dysplasia almost associated with poor prognosis? A case report and review of the literature. Int J Gynecol Cancer. 2006 Mar-Apr;16(2):934-6. doi: 10.1111/j.1525-1438.2006.00216.x. PMID: 16681791.
Aksu G, Fayda M, Saynak M, Karadeniz A. Spinal cord compression due to vertebral hemangioma. Orthopedics. 2008 Feb;31(2):169. doi: 10.3928/01477447-20080201-02. PMID: 19292199.
Karabulut S, Tas F, Tastekin D, Karabulut M, Yasasever CT, Ciftci R, Güveli M, Fayda M, Vatansever S, Serilmez M, Disci R, Aydıner A. The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer. Tumour Biol. 2014 Sep;35(9):8849-60. doi: 10.1007/s13277-014-2151-2. Epub 2014 Jun 3. PMID: 24891186.
Cakir A, Akgun Z, Fayda M, Agaoglu F. Comparison of three dimensional conformal radiation therapy, intensity modulated radiation therapy and volumetric modulated arc therapy for low radiation exposure of normal tissue in patients with prostate cancer. Asian Pac J Cancer Prev. 2015;16(8):3365-70. doi: 10.7314/apjcp.2015.16.8.3365. PMID: 25921146.
Fayda M, Aksu G, Yaman Agaoglu F, Karadeniz A, Darendeliler E, Altun M, Hafiz G. The role of surgery and radiotherapy in treatment of soft tissue sarcomas of the head and neck region: review of 30 cases. J Craniomaxillofac Surg. 2009 Jan;37(1):42-8. doi: 10.1016/j.jcms.2008.07.007. Epub 2008 Sep 18. PMID: 18804382.
Aksu G, Ulutin C, Fayda M, Saynak M. Cerebellar and multiple spinal hemangioblastomas and intraventricular meningioma managed with subtotal resection and external beam radiotherapy; report of a case with literature review. J BUON. 2005 Jul-Sep;10(3):405-9. PMID: 17357198.
Iş G, Taş S, Corapcioğlu F, Fayda M. Is it destiny or just migration pathway theory? Familial germ cell tumor with the same histopathologic subtype in a father and son. Pediatr Neurosurg. 2009;45(2):160. doi: 10.1159/000209658. Epub 2009 Mar 25. PMID: 19321956.
Fayda M, Karanlik H. Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer. Lancet Oncol. 2013 Jun;14(7):e250. doi: 10.1016/S1470-2045(13)70195-5. PMID: 23725703.
Fayda M, Chen R. Axillary vs sentinel lymph node dissection for invasive breast cancer. JAMA. 2011 Jun 8;305(22):2289; author reply 2290-1. doi: 10.1001/jama.2011.753. PMID: 21642673.
Cakir A, Bilge H, Dadaşbilge AK, Fayda EM, Okutan M, Küçücük H. Do collimator angle setup errors cause dose inhomogeneity at the junction zone during craniospinal irradiation? A phantom study. J BUON. 2004 Apr-Jun;9(2):193-6. PMID: 17415814.
Cakir A, Bilge H, Küçücük H, Okutan M, Fayda EM, Darendeliler E. Effect of field placement errors on dose at junction between divergence matching and half-beam block techniques in craniospinal irradiation. J BUON. 2002 Oct-Dec;7(4):361-4. PMID: 17955581.
Ulutin HC, Fayda EM. Retrospective, single-institution study on patterns of failure in male breast carcinoma patients after external beam radiotherapy. Tumori. 2005 Sep-Oct;91(5):443; author reply 443. PMID: 16459646.
Kaytan E, Karadeniz A, Alici S, Fayda M, Kizir A. Unusual metastases from rectal adenocarcinoma; report of two cases with literature review. J BUON. 2002 Oct-Dec;7(4):377-80. PMID: 17955584.
Aksu G, Karadeniz A, Fayda M, Dizdaroglu F. The effect of epithelial and myoepithelial differentiations on survival in a parotid gland undifferentiated carcinoma: case report and review of the literature. J BUON. 2003 Oct-Dec;8(4):389-92. PMID: 17472283.
FAYDA E. M. Endometrium Kanserinde Radyoterapinin Yeri. Turkiye Klinikleri J Gynecol Obst-Special Topic , cilt.7, sa.3, ss.91-99, 2014
CAKIR A., BILGE H. B., DADASBILGE A., KUCUCUK H., OKUTAN M., Fayda E. M. The comparison of Co-60 and 4 MV photons matching dosimetry during half-beam technique. RADIATION MEASUREMENTS , cilt.39, sa.4, ss.447-450, 2005 DOI: 10.1016/j.radmeas.2004.10.001.
Ozen A, Fayda M. Cardiotoxicity After the Lymphoma. Turk J Oncol 2022;37(Supp 1):44–50
Turkkan, G, Bilici N, Sertel H, Tavlı B, Özkırım M, Fayda M. Dosimetric Comparison of Volumetric Modulated Arc Therapy and Dynamic Conformal Arc Therapy in Three fraction Single-isocenter Stereotactic Radiosurgery for Multiple Brain Metastases. Turk J Oncol 2022;37(1):67–73
Fayda M, Gezer U. GAS5 oligonucleotides as therapeutic agents in breast cancer. Transl Cancer Res doi: 10.21037/tcr.2016.08.4 (2016).
Dizdar Y, Küçücük S, Sağlam SK, Fayda M, Uzel O, Camlıca H. Clinical Efficacy of Transdermal Fentanyl in Adults with Cancer-Related Pain:An Open Multicentre Study. Turkiye Klinikleri J Med Sci 2009;29(4):821-5.
Conference Papers and Scientific Presentations
GÜRDAL N., FAYDA E. M., BAKIR B., Alishev N., GEZER U., TAŞTEKİN D., et al. Rektum kanserinde neoadj. sib-vmat yanıtının difüzyon MR ve serum apoptoz marker düzeyleri ile değerlendirilmesi. 12. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 20 - 24 Nisan 2016, ss.45, (Tam Metin Bildiri)
Tukenmez M., Kulle C. B., Velidedeoglu M., Agcaoglu O., Parlakgul G., Aydogan F., et al. Clinical distuingishing characteristics and management of phyllodes tumors of the breast.. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
Altun M., Tambas M., Fayda E. M. Nasopharyngeal carcinoma patients with new primaries.. 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri) DOI: 10.1200/jco.2014.32.15_suppl.6087.
Karanlik H., Saip P., Fayda M., Yavuz E., Eralp Y., Kucucuk S., et al. Magnetic resonance imaging as a predictor of pathologic response rates in patients treated with neoadjuvant chemotherapy. 9th European Breast Cancer Conference (EBCC), Glasgow, Birleşik Krallık, 19 - 21 Mart 2014, cilt.50, (Özet Bildiri)
Goldin G. H., Carter J., Zagar T., Fayda M., Prasad S., Fakiris A., et al. Stereotactic Body Radiation Therapy for Early Stage Lung Cancer: Quantifying the Effect of Tracking With Respiratory Motion on Chest Wall Dosimetry. 55th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Georgia, Amerika Birleşik Devletleri, 22 - 25 Eylül 2013, cilt.87, (Özet Bildiri) DOI: 10.1016/j.ijrobp.2013.06.1944.
IŞIN M., FAYDA E. M., Güveli M., TAMBAŞ M., GEZER U., MERAL R., et al. Circulating Long-none coding RNA (HOTAIR, GAS5, and LyncRNA p-21) levels in patients with nasopharyngeal cancer vs. other inoperable head and neck squamous cell cancer. 6th International Congress on Nasopharyngeal carcinoma, Türkiye, ss.0-38, (Tam Metin Bildiri)
TAMBAŞ M., FAYDA E. M., MERAL R., Güveli M., Özkaya K., ALTUN M. Radiation induced sarcoma in pediatric patients treated for nasopharyngeal carcinoma. 6th International Symposium on Nasopharyngeal Carcinoma, Türkiye, (Tam Metin Bildiri)
IŞIN M., FAYDA M., GÜVELİ M., TAMBAŞ M., GEZER U., MERAL R., et al. Opere edilmemiş başboyun skuamoz hucreli kanserli hastalarda plazma uzun kodlamayan rna ifade duzeyleri. XVII Ulusal Kanser Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2013, ss.379, (Tam Metin Bildiri)
Dağoğlu R. N., SERARSLAN B., FAYDA E. M., Karaman Ş., Çakır A., OKUTAN M., et al. Periorbital cilt kanserlerinde stereotaktik radyoterapi sonuçlarımız. 20. Ulusal Kanser Kongresi, Antalya, Türkiye, ss.265, (Tam Metin Bildiri)
Karaman Ş., Özkaya K., Küçücük S., Köksal C., Nurhat Ü., Dağoğlu R. N., et al. IMRT tekniği kullanarak ışınlanan meme kanserli hastalarımızda dozimetrik ve erken klinik Sonuçlarımız: Tek merkez deneyimi. 20. Ulusal Kanser Kongresi, Antalya, Türkiye, 1 - 04 Nisan 2013, ss.88, (Tam Metin Bildiri)
FRİED D., MİLLER S., FAYDA E. M., MORRİS D., ZAGAR T., LAWRENCE M., et al. Estimating the Alpha/Beta Ratio for Radiation-induced CT Density Changes in Patients Receiving Thoracic Radiation: Comparison of Data from SRS and Conventional Fractionation. 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Boston, Amerika Birleşik Devletleri, 28 - 31 Ekim 2012, ss.675, (Tam Metin Bildiri)
Goldin G. H., Zagar T. M., Fayda M., Marks L. B., Fried D., Miller S. M., et al. Clinical Outcomes of CyberKnife Radiosurgery for Early Stage Lung Cancer: Low Chest Wall Toxicity Rates Associated with Tracking. Chicago Multidisciplinary Symposium in Thoracic Oncology, Illinois, Amerika Birleşik Devletleri, 6 - 08 Eylül 2012, cilt.7, (Özet Bildiri)
FAYDA E. M., RİGUERA D., YİRMİBEŞOĞLU E., LAXRENCE M., RİVERA P., XİE L., et al. The Lack of Association between Cardiopulmonary Dosimetric Parameters and Short-term Changes in Quality of Life Following Thoracic Irradiation. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, New York, Amerika Birleşik Devletleri, 01 Ocak 2011, ss.604-605, (Özet Bildiri)
Almac Z., Fayda M., Asoglu O., Saglam S., Yucel S., Acun H., et al. Early Results of Neoadjuvant Hyperfractionated Accelerated Radiotherapy (HART) with Concurrent and Postoperative Chemotherapy for Locally Advanced Rectal Cancer. 52nd Annual Meeting of the American-Society-For-Radiation-Oncology, California, Amerika Birleşik Devletleri, 31 Ekim - 04 Kasım 2010, cilt.78, (Özet Bildiri) DOI: 10.1016/j.ijrobp.2010.07.713.
AKSU G., YALUG I., ÇORAPCIOĞLU F., FAYDA E. M., BAŞAR E., YALUG K., et al. Post-traumatic stress disorder and risk factors in parents of children with the diagnosis of cancer. 14th European Cancer Conference (ECCO 14), Barcelona, İspanya, 23 - 27 Eylül 2007, cilt.5, sa.4, ss.182, (Tam Metin Bildiri)
Kebudi R., Fayda M., Ayan I., Gorgun O., Dizdar Y., Aksu G., et al. Spontaneous pneumothorax in children with osteosarcoma.. 42nd Annual Meeting of the American-Society-of-Clinical-Oncology, Georgia, Amerika Birleşik Devletleri, 2 - 06 Haziran 2006, cilt.24, (Özet Bildiri)
Özkurt E, Tükenmez M, Çelet B, Öner G, Güven E, Müslümanoğlu M, İğci A, Özmen V, Fayda M, Cabioğlu N. Radiotherapy Does Not Increase Implant/Expander Loss in Breast Cancer Patients Who Underwent Immediate Breast Reconstruction. Annals of Surgical Oncology, Supplement Volume 22(2);May, 2015
Çelet BÖ, Kozanoglu E, Soluk MT, Fayda M. Early fat grafting following PMRT improves cosmetic outcome in two-stage breast reconstruction. Barcelona Breast Meeting 11-13 Mart 2015
Fayda M. Is Sentinel Lymph Node Biopsy Enough for Axillary Macrometastasis? World Congress on Breast Cancer, Birmingham, UK, 2-4 August 2015
Fayda M Local-Regional Therapy Considerations in Patients Receiving Preoperative Chemotherapy. SUNY – YÖK Joint International Public Health and Medical Sciences Conference, April 2015.
Karanlık H, Bayrak S, Fayda M, Özgür İ, Kurul S. Comparison of implant-based immediate breast reconstruction with and without vicryl mesh. 14 th St. Gallen International Breast Cancer ConferencePrimary Therapy of Early Breast Cancer, 2015, 24(1), 132-132.
Serarslan B., Sanli Y., Fayda M., Turkmen C., Erelel M., Kesen N., et al. Evaluation of pulmonary acute/subacute toxicity after different techniques of breast radiotherapy. RADIOTHERAPY AND ONCOLOGY , cilt.119, 2016 DOI: 10.1016/s0167-8140(16)32448-3.
Karanlik H., Ilhan B., Fayda M., Yavuz E., Mudun A., Saip P., et al. Which cytologically proven node-positive breast cancer patients can avoid axillary lymph dissection after neaodjuvant chemotherapy?. CANCER RESEARCH , cilt.73, 2013 DOI: 10.1158/0008-5472.sabcs13-p1-01-22.
Dagoglu N., Karaman S., Sakallioglu B., Fayda M., Saglam S., Sakar B., et al. NEOADJUVANT CHEMORADIOTHERAPY FOR T3-4N0+RECTAL CARCINOMA. RADIOTHERAPY AND ONCOLOGY , cilt.96, 2010
Books and Book Chapters
Türkkan G, Fayda M. Abdominopelvik oligometastatik hastalıkta MRgRT. Özyar E, Önal HC, Fayda M, Selek U, editörler. Radyoterapide Yeni Bir Teknoloji: MR-Linak'ın Güncel Kullanımı. 1. Baskı. Ankara: Türkiye Klinikleri; 2022. p.57-61
Tambaş M, Fayda M. Yaşlıda Santral Sinir Sistemi Kanserleri. Saka B, editör. Geriatrik Onkoloji. Ankara: Türkiye Klinikleri; 2018. p. 28-35.
Appointments and Contact
Contact us for an appointment with Prof. Dr. Emre Merdan Fayda and information about treatment.
Free consultation and patient coordination
-
0+
Total Online Enquiries
-
0+
Total Number Of Online Appointment Protocols
-
0+
Total Doctors
-
0+
Total Partner Hospitals
Accessing Healthcare is Now Easier!
The Address of Trust in Healthcare ServicesCatalogs
You can find detailed information about our services and processes.
AU